Can pick them today TIMBERRRR easy money. Watch me sell the $49 PUTS also this week then my JAN $48.5 and $48 also in play Merry Christmas....lol
The grimstalker Troll aka stoopid ref steve & the gizboi Troll now there's a pair to draw to LOL.
You 2 can really pick them LMAO!
Sentiment: Strong Buy
I am stepping up to the plate in a big big way this morning to buy all the Merck I possibly can!
back down. Its foolish not to take profits at this 5 year high and rebuy when back to $47.5. Blink once and the PPS of $50 will be one blink again and $49 PPS will also be gone.
Agreed MRK paid 14% this year vs 27% average on the S and P. At these levels its absolutly foolish not to take profits and rebuy at lower levels. This PPS will not hold MRK is not doing well revenue down 35% and no growth expected for next two years.
WE WERE PROMISED BY THE DOC'S DECADES AGO, OF A CURE FOR CANCER. THE DOC'S LIED!
But not to worry, they still make the big bucks as cancer is indeed a very lucrative business.
The reality though is, 500 years from now, the doc's will still be promising a cure for cancer.
SUCKERS!! IT'S ALL ABOUT THE MONEY.
Easy Money for all Merck longs.
Big #$%$ deal POSe stock makes a couple of pennies after it loses tons of $. I'll eat it when this hits in the $60's and holds. Look all the other stosks that make $ morons.
Dump it now and grab ur pennies, hurry up.
Name calling clearly indicates that you have been not only owned, but also biotch slapped down very hard. HaaaaaHaaaaaa
Legally, pink slips sent out by Merck would have no standing at ERTs
unless those companies agreed. While executives at ERTs declined to
comment, employees at those companies said they were not inclined to
"This is ridiculous. I don't work for Merck. They can't fire me," said
Kaili Blackburn, a flight attendant with American Airlines.
Reactions like that, replied the Merck spokesperson "are not very
Inspiration for Merck's plan came from previous cutback initiatives,
said company officials. In January of 2005, for instance, the company
announced it would trim 18,000 jobs over two years. However, just a year
later, Merck said it had already reached its quota. "We were quite
surprised at the number of employees willing to leave Merck in such a
hurry, and we decided to build on that,".
Analysts credited the short-term vision, noting that the announcement
had the desired effect of immediately increasing Merck's share value.
However, the long-term ramifications could be detrimental, said Morgan Stanley analyst Beldon McInty.
"It's a little early to tell, but by eliminating all its employees,
Merck may jeopardize its market position and could, at least
theoretically, cease to exist," said McInty.
The spokesperson, however, urged patience: "To my knowledge, this hasn't
been done before, so let's just wait and see what happens."